One-Pager
Impella Heart Pump
Microaxial pumps for shock and high-risk PCI: signals, purge, alarms, care
Download one-page PDFLetter landscape, ready to print or keep with your notes
How it works
A catheter-mounted microaxial pump crosses the aortic valve, moving blood from the LV into the aorta. Flow is continuous, with no ECG or pressure trigger (unlike the IABP).
- Unloads the LV: lower LVEDP and PAOP, less work
- Adds forward flow: higher MAP, cardiac output, coronary perfusion
- Preload dependent: needs LV filling and a working RV
- If VA-ECMO starts, may stay in to unload the LV
| Pump | Access | Flow | Labeled use |
|---|---|---|---|
| CP | Femoral or axillary artery | 3.3–3.7 L/min (peaks 4.3) | HRPCI ≤6 h; shock ≤4 days |
| 5.5 | Surgical axillary graft or aorta | Up to 5.5 L/min | Shock ≤14 days; can walk |
| RP Flex | IJ or femoral vein to PA | About 4 L/min | RV failure after LVAD, MI, transplant or surgery; ≤14 days |
Who gets one
Indications: shock from isolated LV failure <48 h after MI or heart surgery, or from cardiomyopathy (including peripartum) or myocarditis, despite fluids, pressors and inotropes. Also high-risk PCI in stable patients (heart team decision).
Contraindications (left-sided pumps):
- LV mural thrombus
- Mechanical aortic valve or heart constrictive device
- Aortic stenosis or calcification, valve area ≤0.6 cm²
- Moderate to severe aortic regurgitation
- Severe PAD blocking access
- ASD or VSD, including post-MI VSD
- Shock only: RV failure, LV rupture, tamponade, heart-lung failure
DanGer Shock (2024): in STEMI shock, Impella CP lowered 180-day mortality (46% vs 59%) but raised bleeding, limb ischemia and dialysis. 2025 ACC/AHA ACS guideline: microaxial pump class 2a in selected STEMI with severe or refractory shock; routine IABP class 3.
Reading the controller
P-levels (P-0 to P-9) set motor speed.
| Signal | Correct | Malpositioned |
|---|---|---|
| Placement signal (outlet sensor) | Aortic waveform | Ventricular: outlet in LV, too deep |
| Motor current | Pulsatile: inlet in LV, outlet in aorta | Flat: whole pump in LV or in aorta |
| Echo (CP) | Inlet 3.5 cm below the valve | Over 4 cm deep, or inlet in aorta |
Purge system
Pressurized purge fluid keeps blood out of the motor.
- Base: dextrose in water (D5W recommended; 5–20% allowed). Never saline.
- Add heparin 25 or 50 units/mL, or bicarbonate 25 or 50 mEq/L if heparin is contraindicated. Never both; no other anticoagulant.
- Purge pressure 300–1100 mmHg; flow 2–30 mL/h
- Purge heparin counts toward the total heparin dose
- Cassette change: finish within 90 s of luer disconnection
Alarms and first moves
| Alarm | Likely cause | First moves |
|---|---|---|
| Suction | Underfilled LV (volume, RV failure) or inlet on wall | Lower P-level; check volume, RV, position |
| Position in ventricle or in aorta | Whole pump on one side of valve | P-2; provider repositions with imaging |
| Placement signal low | Outlet at valve, too deep; motor current pulsatile | Assess LV function; imaging; provider repositions |
| Purge pressure low (<300) | Leak or dextrose too dilute | Find leak; raise dextrose; new cassette |
| Purge pressure high (≥1100) or blocked | Kink or dextrose too strong | Unkink; switch to D5W; watch motor current |
| Impella stopped | Backflow into LV | Restart, or withdraw pump from LV |
Complications and nursing care
| Complication | Watch for |
|---|---|
| Hemolysis | Dark, red or pink urine; falling Hgb; plasma free Hgb >40 mg/dL |
| Limb ischemia | Cool, pale, pulseless leg; may need an antegrade perfusion sheath |
| Bleeding | Site hematoma; retroperitoneal flank pain, hypotension |
| Also | AKI, stroke, valve or vessel injury, low platelets |
- Femoral: leg straight (knee immobilizer), HOB ≤30°; turn with care (pump can shift)
- Pulses, color, warmth, site; hourly urine output and color
- Heparin per protocol (IFU ACT 160–180 s; aPTT or anti-Xa common)
- RV failure: rising CVP, low flows, suction
- Weaning: down 2 P-levels at a time; ≥P-2 until pulled from LV; sheath out at ACT <150 s
- Transport: battery ≥60 min; no commercial flights; air transport needs grounding and Flight Mode
In depth
The one-page summary above is what the PDF prints. These sections go further.
Hemodynamics in depth
The Impella is a continuous-flow axial pump in series with the LV: the inlet draws blood from the cavity and the impeller ejects it just above the aortic valve. Speed is fixed by the P-level, with no ECG or pressure trigger, so it pumps through VT, VF and asystole as long as the LV fills. An IABP adds about 0.5–1 L/min by displacement; a CP adds 3.5–4 L/min and a 5.5 up to 5.5 L/min of forward flow.
Unloading works at both ends of the coronary perfusion gradient: emptying the LV lowers LVEDP, PAOP and wall stress, so the pressure-volume loop shifts left and oxygen demand falls, while forward flow raises aortic diastolic pressure. Native ejection falls as support rises, so pulse pressure narrows; follow MAP, cardiac power output and LVEDP instead.
Flow at any P-level depends on the pressure difference across the pump, small in systole and large in diastole, so flow and motor current swing with every beat. The pump is preload dependent: hypovolemia, RV failure, tamponade or a large PE starve the inlet and cause suction. The RP Flex is the mirror image, moving blood from the right atrium to the pulmonary artery to lower CVP and raise LV preload; if the LV cannot accept the return, a left pump is needed too (BiPella).
Cardiac power output (W) = MAP × CO ÷ 451; below 0.6 W carried the highest mortality in the SHOCK trial registry (Fincke 2004). PAPi = (PA systolic − PA diastolic) ÷ RA pressure; below 0.9 with RA pressure above 12 mmHg points to RV failure that a left-sided pump cannot fix.
Device family and selection
| Pump | Motor and shaft | Access | Flow and US label |
|---|---|---|---|
| CP | 14 Fr motor, 9 Fr shaft, pigtail | 14 Fr peel-away; femoral or axillary | 3.7 L/min (peak 4.3); HRPCI 6 h, shock 4 days |
| 5.5 | 19 Fr motor, 9 Fr shaft, no pigtail | 23 Fr peel-away via 10 mm axillary graft | 5.5 L/min; shock 14 days |
| RP Flex | 22 Fr cannula, 11 Fr shaft, 6 Fr pigtail | 23 Fr peel-away; right IJ or femoral vein | About 4 L/min; RV failure 14 days |
The CP is for support in minutes: AMI shock, high-risk PCI, a bridge to a decision. The 5.5 is for more flow or more time: post-cardiotomy shock, myocarditis, chronic heart failure bridged to LVAD or transplant, or an upgrade from a CP; the axillary route frees the groin and lets the patient walk. The RP Flex is for isolated RV failure after LVAD, RV infarct, transplant or cardiac surgery, or joins a left pump when CVP climbs and the left pump keeps sucking.
- LV thrombus: the inlet would aspirate and embolize it
- Mechanical aortic valve or stenosis ≤0.6 cm²: the cannula cannot cross or jams the leaflets
- Moderate or severe aortic regurgitation: pumped blood leaks straight back and the leak worsens
- ASD or VSD: lowering LV pressure reverses the shunt toward the aorta
- Severe PAD: a 14 Fr sheath occludes a 5 mm artery; go axillary
- RV failure, tamponade, LV rupture: the LV cannot fill, so the pump only sucks
Insertion and position management
Femoral CP insertion: ultrasound-guided puncture of the common femoral artery, an angiogram to size the vessel (ideally ≥6 mm), pre-close sutures before the 14 Fr peel-away sheath, a 0.018-inch wire placed in the LV through a diagnostic catheter, the pump advanced over it under fluoroscopy and started at P-2. The peel-away sheath is then split off and the repositioning sheath advanced, leaving the 9 Fr shaft in the artery. The 5.5 needs a cutdown and a 10 mm graft on the axillary artery under TEE; the RP Flex passes from the right IJ or femoral vein through the tricuspid and pulmonary valves to the main PA.
Position is confirmed two ways. Fluoroscopy: inlet below the aortic annulus, pigtail free in the LV, cannula off the septum. Echo (parasternal long axis): annulus-to-inlet distance 3.5 cm for the CP and 5 cm for the 5.5, pump pointing at the apex, nothing caught in the mitral chordae. Record the shaft marker number at the sheath hub every shift.
Pumps migrate. Inward (hip flexion, coughing, a loosened sheath) puts the inlet against the wall or mitral apparatus: suction, hemolysis, a damped motor current. Outward (tension on the shaft, turning, transport) brings the outlet toward the valve: Placement Signal Low, then an in-ventricle or in-aorta alarm, finally a flat current. The nurse catches the change in marker, signal shape or flow and calls; only a credentialed clinician repositions, under echo or fluoroscopy, at P-2 during the move.
The SmartAssist screen
The home screen shows the alarm banner (red critical, yellow serious, white advisory), P-level and Impella flow, the placement signal and motor current waveforms, and purge and power status. The placement signal comes from an optical pressure sensor at the outlet; on the CP and 5.5 it is an aortic pressure, so it doubles as a second arterial line. From that pressure and the gradient implied by motor current the controller reconstructs LV pressure and displays LVEDP; entering a thermodilution or Fick cardiac output adds cardiac power output and native cardiac output (entered CO minus Impella flow).
| Value | Normal | What a change means |
|---|---|---|
| Placement signal | Aortic shape, dicrotic notch; MAP ≥65 | Ventricular shape: outlet in LV; damped: weak LV |
| Motor current (mA) | Pulsatile, swings with each beat | Flat: both ends in one chamber; slow rise: thrombus |
| Impella flow | Steady for the P-level (CP P-8 about 3.3–3.5) | Lower: MAP up, suction, malposition, clot |
| LVEDP | Falling toward 10–18 mmHg | >20 under-unloaded; <8 with suction: dry |
| Purge pressure | 300–1100 mmHg | <300 leak or dilute; >1100 kink, clot, strong |
Read the waveforms together. Aortic placement signal plus pulsatile current: the pump straddles the valve. Ventricular placement signal (low diastolic, wide swing) with pulsatile current: the outlet has slipped into the LV. Flat current: both ends are in one chamber, and the placement signal tells you which. A weak LV, arrest or VA-ECMO dampens both and produces Impella Position Unknown: examine the patient and get an echo. Flow is calculated, not measured, so it is wrong whenever the pump is malpositioned; a fall in flow at the same P-level is afterload, suction, malposition or clot until proven otherwise.
Troubleshooting alarm by alarm
| Alarm | Check | Action |
|---|---|---|
| Suction | Volume, CVP, bleeding; echo LV size and position | Down 1–2 P-levels; fill or support the RV; reposition |
| Position In Ventricle / In Aorta | Both waveforms; marker at hub; echo | P-2; provider repositions under imaging |
| Purge Pressure Low (<300) | Luers, cassette, empty bag, dextrose strength | Fix leak; new bag; raise dextrose (D5 to D20) |
| Purge Pressure High (>1100) | Kinks, clamps, dextrose strength, clot in motor | Unkink; lower dextrose (D20 to D5); watch current |
| Purge Flow Decreased / Increased | Trend of pressure and flow over hours | Pressure up with flow down: thrombus risk, call |
| Impella Stopped | Cable, controller, catheter fault | Restart or backup controller; else P-0 and withdraw |
Suction means the inlet cannot get blood: the LV is empty (hypovolemia, bleeding, RV failure, tamponade, vasodilation) or the inlet is on the wall. Raising the P-level pulls harder on an empty chamber; drop one or two levels and fix the filling. Suction with rising CVP and falling PAPi is the RV (inotropes, pulmonary vasodilators, RP Flex); suction with hemolysis and a damped current is position.
Purge alarms follow one rule: at a fixed viscosity, pressure tracks resistance. Low pressure means fluid is escaping (loose luer, cracked cassette, empty bag) or is thinner than expected; high pressure means a kink, a closed clamp, thicker fluid, or protein and thrombus narrowing the purge gap in the motor. The controller adjusts purge flow between 2 and 30 mL/h to hold pressure, so a slow pressure rise with falling flow over a shift is the earliest sign of pump thrombosis. Call the MCS coordinator or perfusion for a purge alarm a kink check does not clear, the interventionalist for a position alarm, and Abiomed's Clinical Support Center (1-800-422-8666, 24 hours).
Complications
Hemolysis is shear injury in the impeller; its drivers are the suction list plus speed: inlet near a wall or the chordae, an underfilled LV, a high P-level in a small cavity, thrombus on the impeller. Recognize it by pink or dark urine, plasma free hemoglobin above 40 mg/dL (IBCC), rising LDH and bilirubin, low haptoglobin, and a falling hemoglobin without bleeding. Free hemoglobin scavenges nitric oxide and clogs tubules, so AKI follows; renal replacement therapy was needed in 41.9% of Impella patients versus 26.7% of controls in DanGer Shock. Management: echo the position first, then the lowest P-level that holds MAP and CPO, volume, the purge pressure trend for thrombus, and an upgrade to a 5.5 or removal if it persists.
Limb ischemia follows from a 14 Fr sheath in a common femoral artery of 6–7 mm, less in women, diabetics and peripheral disease; DanGer Shock recorded it in 5.6% of Impella patients versus 1.1% of controls. Prevention: ultrasound and angiographic sizing, downsizing to the repositioning sheath, and in small vessels a prophylactic antegrade perfusion sheath (5–7 Fr in the superficial femoral artery, fed from the introducer side arm). Assess hourly: Doppler at the dorsalis pedis and posterior tibial, color, temperature, capillary refill, motor and sensory function, calf tension; near-infrared oximetry on both calves falls before pulses disappear. Treatment escalates from a perfusion sheath or external bypass, to thrombectomy or fasciotomy, to removing the pump or moving to the axillary artery.
Bleeding comes from the access site, the retroperitoneum when the puncture was above the inguinal ligament (flank pain, falling hemoglobin, clean groin), the GI tract, and acquired von Willebrand syndrome from shearing of the large vWF multimers; new thrombocytopenia prompts a HIT workup because purge heparin is a continuous exposure. Aortic regurgitation worsens the longer the cannula sits across the valve, so serial echo looks at the valve as well as the position. Stroke, pump thrombosis (rising purge pressure and motor current, falling flow), site infection and ventricular arrhythmias complete the list; a patient in sustained VT with a working pump can keep a MAP of 65 mmHg, so treat per ACLS and drop the P-level only if suction alarms.
ECMO plus Impella (ECPELLA)
Peripheral VA-ECMO returns blood retrograde up the aorta, raising LV afterload when the LV is least able to eject: the ventricle distends, the aortic valve stops opening, blood stagnates in the LV and root, and the lungs flood. An Impella across the valve vents the LV directly; the combination is ECPELLA. In 255 propensity-matched pairs (Schrage, Circulation 2020) unloading was associated with lower 30-day mortality (HR 0.79, 95% CI 0.63–0.98) at the price of more severe bleeding (38.4% vs 17.9%), access-site ischemia (21.6% vs 12.3%) and renal replacement therapy (58.5% vs 39.1%). The randomized UNLOAD ECMO trial is still enrolling.
The console reads differently on ECMO: aortic pressure is set by the ECMO pump, so the placement signal is a near-flat line at the MAP; the LV is small, so motor current loses its swing and Impella Position Unknown is common; and flow at a given P-level is lower because the pump works against a higher aortic pressure. The target is the lowest P-level that keeps the LV decompressed: a pulse pressure on the arterial line, the aortic valve opening on echo, LVEDP or PAOP below about 18 mmHg, no new pulmonary edema. Too much Impella empties the LV (suction, hemolysis); too little leaves it distended with echo contrast and thrombus.
Two traps. With femoral VA-ECMO and failing lungs the Impella pumps blood that has passed through the lungs to the coronaries and brain before the ECMO blood reaches them, so it delivers hypoxemic blood to the organs that matter most (north-south syndrome): monitor a right radial ABG and fix oxygenation first. Anticoagulation is one system: purge heparin counts toward the dose and a HIT diagnosis changes both circuit and purge. Weaning is usually ECMO first, leaving the Impella as the LV bridge.
Daily care, weaning and explant
- Each shift: neuro check, MAP, CPO, LVEDP, PA catheter numbers if present; P-level, flow, both waveforms, purge pressure and flow, purge fluid and additive, bag volume, cassette date, marker at the hub, backup controller at the bedside
- Hourly: urine output and color; limb Doppler, color, temperature, capillary refill, motor and sensory function; knee immobilizer and HOB ≤30° for femoral access; no cuffs or sticks on a 5.5 arm
- Labs: ACT 160–180 s per IFU, or aPTT or anti-Xa per protocol; hemoglobin and platelets every 6–12 h; creatinine, plasma free hemoglobin and LDH daily; purge heparin counts (25 units/mL at 10 mL/h is 250 units/h)
- Handling: one person holds the catheter when turning; femoral pumps stay in bed with the leg straight; axillary 5.5 and IJ RP Flex patients can walk with a trained team
Weaning starts when the cause has been treated and the numbers hold without escalation: MAP ≥65 mmHg on no or low-dose vasopressors, CPO >0.6 W, lactate cleared, LVEDP or PAOP under about 18 mmHg, urine output back, and an echo showing improving ejection. The CP comes down 2 P-levels at a time (the 5.5 one level), with 15–60 minutes or longer between steps depending on the program. Most programs hold at P-2 for 30 minutes to a few hours before explant; the IFU calls all of this guidance only.
For a femoral CP the interventionalist pulls the pump into the descending aorta at P-2, sets P-0 and removes the catheter; the sheath comes out when ACT is below 150 s, with 40 minutes of manual pressure per the IFU or closure of the pre-placed sutures, then about 6 hours of bedrest with the leg straight. The 5.5 comes out through the graft, which is then ligated; the RP Flex like a large venous sheath. Afterward: neurovascular checks every 15 minutes for an hour, then hourly; watch for hematoma, pseudoaneurysm and retroperitoneal bleeding; LDH and creatinine lag the pump by a day or two.
Evidence and controversies
| Trial | Patients | Comparison | Main result |
|---|---|---|---|
| ISAR-SHOCK 2008 | 26 AMI shock | Impella 2.5 vs IABP | CI +0.49 vs +0.11 L/min/m²; 30-d death 46% both |
| PROTECT II 2012 | 452 high-risk PCI | Impella 2.5 vs IABP | 30-d MAE 35.1% vs 40.1% (NS); 90-d 40.6% vs 49.3% |
| IMPRESS 2017 | 48 AMI shock, 92% post-arrest | Impella CP vs IABP | 30-d death 46% vs 50%; major bleeding 33% vs 8% |
| NCSI 2022 (registry) | 406 AMI shock | Impella before PCI by protocol | 71% survival to discharge |
| DanGer Shock 2024 | 360 STEMI shock | Impella CP vs standard care | 180-d death 45.8% vs 58.5% (HR 0.74); harms 24.0% vs 6.2% |
DanGer Shock is the first randomized trial to show a survival benefit for any mechanical support device in cardiogenic shock. Number needed to treat at 180 days was about 8; number needed to harm for the composite of severe bleeding, limb ischemia, hemolysis, device failure or worsening aortic regurgitation was about 6, and dialysis rose from 26.7% to 41.9%. It succeeded where IMPRESS failed by enrolling STEMI with lactate ≥2.5 mmol/L and LVEF <45%, excluding comatose arrest survivors, RV failure and mechanical complications, and placing the pump before or during PCI. The 2025 ACC/AHA ACS guideline made this a class 2a recommendation for a microaxial pump in selected STEMI patients with severe or refractory shock, with class 3 for routine IABP. VA-ECMO showed no survival benefit in ECLS-SHOCK (2023: 30-day death 47.8% vs 49.0%), and PROTECT II was stopped for futility, so high-risk PCI support rests on weaker evidence.
Still open: whether the benefit extends to NSTEMI, non-ischemic shock or arrest survivors; whether centers without a limb-protection and hemolysis protocol can reproduce the net benefit; and how to weigh the registries that found more death and bleeding with Impella than IABP (Dhruva 2020: in-hospital death 45.0% vs 34.1% in 1,680 matched pairs). PROTECT IV (high-risk PCI) and UNLOAD ECMO are still enrolling. Practice also varies on heparin versus bicarbonate purge and on ACT 160–180 s per IFU versus aPTT or anti-Xa targets.
Exam pearls
- Correct position = aortic placement signal + pulsatile motor current; ventricular signal = outlet too deep; flat current = both ends in one chamber
- Suction = underfilled LV or inlet on the wall: lower the P-level, give volume, check the RV and position; never raise it
- Purge: dextrose with heparin 25 or 50 units/mL or bicarbonate 25 or 50 mEq/L, never saline, never both; low pressure = leak or dilute, high = kink, clot or strong
- Never P-0 or P-1 across the valve: blood flows backward into the LV; weaning stops at P-2 until explant
- Hemolysis: pink urine, plasma free hemoglobin >40 mg/dL, rising LDH, low haptoglobin; echo the position first, then lower the P-level
- CPO = MAP × CO ÷ 451, <0.6 W is inadequate; PAPi <0.9 with RA >12 mmHg is RV failure a left pump cannot fix
- DanGer Shock 2024: Impella CP in STEMI shock, 180-day death 45.8% vs 58.5%, more bleeding, limb ischemia and dialysis; 2025 ACC/AHA class 2a
Related one-pagers
- IABP ManagementCounterpulsation, triggers, the four timing errors, nursing care and weaning
- ECMO EssentialsVA vs VV, the circuit, monitoring, troubleshooting and ECPR for CCRN, CMC, CSC and transport exams
- LVAD BasicsHeartMate 3 parameters, alarms, complications, anticoagulation and arrest care for critical care and transport exams
Sources
- Abiomed (Johnson & Johnson MedTech). Impella CP with SmartAssist for Use During Cardiogenic Shock and High-Risk PCI: Instructions for Use and Clinical Reference Manual (US), V11.1, Document No. 0048-9007 rV, February 2026. Link
- Abiomed (Johnson & Johnson MedTech). Impella 5.5 with SmartAssist for Use During Cardiogenic Shock: Instructions for Use and Clinical Reference Manual, Document No. 10003049 rL, February 2026. Link
- Abiomed (Johnson & Johnson MedTech). Impella RP Flex with SmartAssist System: Instructions for Use and Clinical Reference Manual (US), Document No. 10003286 Rev. J, April 2026. Link
- HeartRecovery.com (Abiomed). Impella Important Safety Information, accessed October 2026. Link
- HeartRecovery.com (Abiomed). Impella CP with SmartAssist product page, accessed October 2026. Link
- HeartRecovery.com (Abiomed). Impella 5.5 with SmartAssist product page, accessed October 2026. Link
- HeartRecovery.com (Abiomed). Impella RP Flex with SmartAssist product page, accessed October 2026. Link
- Johnson & Johnson MedTech. Impella heart pumps product page, accessed October 2026. Link
- Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025;151(13):e771-e862. doi:10.1161/CIR.0000000000001309. PMID 40014670. Link
- TCTMD. ACC/AHA Release New Comprehensive ACS Guidelines. February 27, 2025. Link
- American College of Cardiology. Cardiogenic Shock and Mechanical Circulatory Support: Year in Review 2025. August 2026. Link
- Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A Review of the Impella Devices. Interv Cardiol. 2022;17:e05. Link
- Farkas J. Impella. Internet Book of Critical Care (EMCrit), updated October 14, 2024. Link
- AACN Certification Corporation. CCRN Exam Handbook, Direct Care, July 2026 (Adult CCRN test plan for exams on and after November 12, 2025). Link
- Stony Brook Medicine. Procedure for anticoagulation with heparin for patients with an IMPELLA device (not on ECMO), January 17, 2019. Link